Need for More Comprehensive Evaluation of Immune-Related Adverse Events in Immunotherapy for Biliary Tract Cancer

JAMA Oncol. 2020 Dec 1;6(12):1981. doi: 10.1001/jamaoncol.2020.4815.

Authors

Dongxu Wang¹, Samuel Seery², Haitao Zhao¹

Affiliations

¹ Peking Union Medical College Hospital, Department of Liver Surgery, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
² Peking Union Medical College, Chinese Academy of Medical Sciences and Peking Union Medical College School of Humanities and Social Sciences, Beijing, China.

PMID: 33090192
DOI: 10.1001/jamaoncol.2020.4815

No abstract available

Publication types

Letter
Comment

MeSH terms

Bile Duct Neoplasms*
Biliary Tract Neoplasms* / therapy
Humans
Immunotherapy / adverse effects
Nivolumab

Substances

Nivolumab